Shelly Peyton to Antineoplastic Agents
This is a "connection" page, showing publications Shelly Peyton has written about Antineoplastic Agents.
Connection Strength
0.641
-
Brooks EA, Galarza S, Gencoglu MF, Cornelison RC, Munson JM, Peyton SR. Applicability of drug response metrics for cancer studies using biomaterials. Philos Trans R Soc Lond B Biol Sci. 2019 08 19; 374(1779):20180226.
Score: 0.440
-
Schwartz AD, Barney LE, Jansen LE, Nguyen TV, Hall CL, Meyer AS, Peyton SR. A biomaterial screening approach reveals microenvironmental mechanisms of drug resistance. Integr Biol (Camb). 2017 Dec 11; 9(12):912-924.
Score: 0.099
-
Nguyen TV, Sleiman M, Moriarty T, Herrick WG, Peyton SR. Sorafenib resistance and JNK signaling in carcinoma during extracellular matrix stiffening. Biomaterials. 2014 Jul; 35(22):5749-59.
Score: 0.077
-
Landry BD, Leete T, Richards R, Cruz-Gordillo P, Schwartz HR, Honeywell ME, Ren G, Schwartz AD, Peyton SR, Lee MJ. Tumor-stroma interactions differentially alter drug sensitivity based on the origin of stromal cells. Mol Syst Biol. 2018 08 06; 14(8):e8322.
Score: 0.026